🟢 Biomea Fusion is trading 8% up in pre-market with no confirmed company-specific catalyst identified

Biomea Fusion is trading 8.03% up at $1.48, with no confirmed company-specific catalyst identified.

• The stock rose from the August 21 close of $1.37.
• No fresh company-specific announcement was found for August 24, 2026. The latest identified update, on August 13, was first patient dosing in an obesity study and may be a background catalyst, but is not a confirmed explanation for the move.
• Broader markets are lower, so market sentiment does not explain the gain.